Norwegen. SERAF launches final evaluation report for heroin assisted treatment in Norway
Norwegen. SERAF launches final evaluation report for heroin assisted treatment in Norway
This report presents the evaluation of heroin-assisted treatment in Norway, published on June 8th, 2026.
Heroin-assisted treatment (HAT) was introduced in Oslo and Bergen in 2022, as a new treatment option for people with severe, long-standing opioid dependence for whom existing interventions have not provided sufficient benefit. HAT offers supervised intake of pharmaceutical heroin (diacetylmorphine) within a structured, multidisciplinary program with twice-daily dosing and access to medical and psychosocial follow-up. The evaluation, led by SERAF at the University of Oslo in collaboration with RusForsk, the Addiction Clinic at Haukeland University Hospital, and the user organization ProLAR Nett, has followed patients, services, and outcomes over four years. (University of Oslo, Norwegian Centre for Addiction Research, Norwegen, 05.07.2026)